retinitis pigmentosa

Abu Dhabi opens UAE's first gene therapy trial for MerTK-linked retinal blindness

The Department of Health Abu Dhabi has initiated the UAE's first gene therapy trial, targeting MerTK-related retinitis pigmentosa, a rare inherited condition causing progressive blindness. The trial confirms a working regulatory pathway for advanced therapies in the emirate.